Concepedia

Publication | Open Access

Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study

83

Citations

25

References

2015

Year

Abstract

Two years after initiating MS-modifying therapy, only 30-40% of patients were adherent to DMDs.

References

YearCitations

Page 1